60 Degrees Pharmaceuticals (SXTPW) Competitors $0.04 0.00 (0.00%) As of 08/1/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock SXTPW vs. ATNFW, DRTSW, APLMW, BCTXW, CDIOW, CELUW, CEROW, CINGW, CLNNW, and COEPWShould you be buying 60 Degrees Pharmaceuticals stock or one of its competitors? The main competitors of 60 Degrees Pharmaceuticals include 180 Life Sciences (ATNFW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Celularity (CELUW), CERo Therapeutics (CEROW), Cingulate (CINGW), Clene (CLNNW), and Coeptis Therapeutics (COEPW). These companies are all part of the "biotechnology" industry. 60 Degrees Pharmaceuticals vs. Its Competitors 180 Life Sciences Alpha Tau Medical Apollomics BriaCell Therapeutics Cardio Diagnostics Celularity CERo Therapeutics Cingulate Clene Coeptis Therapeutics 180 Life Sciences (NASDAQ:ATNFW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership. Does the media favor ATNFW or SXTPW? In the previous week, 180 Life Sciences had 2 more articles in the media than 60 Degrees Pharmaceuticals. MarketBeat recorded 2 mentions for 180 Life Sciences and 0 mentions for 60 Degrees Pharmaceuticals. 180 Life Sciences' average media sentiment score of 0.48 beat 60 Degrees Pharmaceuticals' score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media. Company Overall Sentiment 180 Life Sciences Neutral 60 Degrees Pharmaceuticals Neutral Is ATNFW or SXTPW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A 60 Degrees Pharmaceuticals N/A N/A N/A Which has higher earnings & valuation, ATNFW or SXTPW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/A60 Degrees Pharmaceuticals$665.45KN/AN/AN/AN/A Summary180 Life Sciences beats 60 Degrees Pharmaceuticals on 2 of the 3 factors compared between the two stocks. Get 60 Degrees Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SXTPW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SXTPW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SXTPW vs. The Competition Export to ExcelMetric60 Degrees PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$134.50M$5.48B$9.54BDividend YieldN/A3.74%4.73%4.09%P/E RatioN/A3.8128.8623.83Price / SalesN/A4,246.60371.4566.14Price / CashN/A13.1935.4557.96Price / BookN/A39.388.265.54Net IncomeN/A-$90.99M$3.25B$259.28M7 Day PerformanceN/A-1.84%-3.75%-4.67%1 Month PerformanceN/A11.20%4.27%4.37%1 Year PerformanceN/A189.79%25.85%17.91% 60 Degrees Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SXTPW60 Degrees PharmaceuticalsN/A$0.04flatN/A-13.9%$0.00$665.45K0.002ATNFW180 Life SciencesN/A$0.01+2.1%N/A+18.6%$0.00N/A0.007News CoveragePositive NewsGap UpDRTSWAlpha Tau MedicalN/A$0.23-13.3%N/A+35.6%$0.00N/A0.0080Gap DownAPLMWApollomicsN/A$0.03-8.6%N/A+228.0%$0.00N/A0.0059BCTXWBriaCell TherapeuticsN/A$0.06-2.0%N/A-82.0%$0.00N/A0.008Short Interest ↑CDIOWCardio DiagnosticsN/A$0.01-5.6%N/A-70.4%$0.00$19.90K0.007Short Interest ↑Gap UpCELUWCelularityN/A$0.05+0.2%N/AN/A$0.00$54.22M0.00220News CoveragePositive NewsGap DownCEROWCERo TherapeuticsN/A$0.03-2.2%N/A-41.3%$0.00N/A0.008Short Interest ↑Gap DownCINGWCingulateN/A$0.15-12.8%N/A+817.4%$0.00N/A0.0020Gap DownCLNNWCleneN/A$0.03-0.7%N/A-2.0%$0.00$350K0.00100Gap UpCOEPWCoeptis TherapeuticsN/A$0.04+6.0%N/A+19.1%$0.00$62.87K0.004 Related Companies and Tools Related Companies ATNFW Alternatives DRTSW Alternatives APLMW Alternatives BCTXW Alternatives CDIOW Alternatives CELUW Alternatives CEROW Alternatives CINGW Alternatives CLNNW Alternatives COEPW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SXTPW) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 60 Degrees Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 60 Degrees Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
